75 related articles for article (PubMed ID: 2561834)
1. A new analysis of whole-body calorimetry data.
Lynch TJ; Martinez RP; Furman MB; Geller EB; Adler MW
NIDA Res Monogr; 1989; 95():289-90. PubMed ID: 2561834
[No Abstract] [Full Text] [Related]
2. Kappa antagonist effects of buprenorphine in the rat drug-discrimination procedure.
Negus SS; Picker MJ; Dykstra LA
NIDA Res Monogr; 1989; 95():518-9. PubMed ID: 2561845
[No Abstract] [Full Text] [Related]
3. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
4. Effects of morphine tolerance-dependence and abstinence on kappa-opiate receptors of rat brain and spinal cord.
Bhargava HN; Gulati A; Rahmani NH
Biochem Pharmacol; 1991 Aug; 42(6):1302-6. PubMed ID: 1653568
[No Abstract] [Full Text] [Related]
5. Selective kappa opioid agonist for spinal analgesia without the risk of respiratory depression.
Castillo R; Kissin I; Bradley EL
Anesth Analg; 1986 Apr; 65(4):350-4. PubMed ID: 3006552
[TBL] [Abstract][Full Text] [Related]
6. U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
Vonvoigtlander PF; Lahti RA; Ludens JH
J Pharmacol Exp Ther; 1983 Jan; 224(1):7-12. PubMed ID: 6129321
[TBL] [Abstract][Full Text] [Related]
7. Similar actions of kappa and mu agonists on spinal nociceptive reflexes in rats and their reversibility by naloxone.
Parsons CG; West DC; Headley PM
NIDA Res Monogr; 1986; 75():461-4. PubMed ID: 2828992
[TBL] [Abstract][Full Text] [Related]
8. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices.
Suarez-Roca H; Maixner W
J Pharmacol Exp Ther; 1993 Feb; 264(2):648-53. PubMed ID: 7679733
[TBL] [Abstract][Full Text] [Related]
9. Differential activity of selective opioid agonists on hypothalamic magnocellular neuronal activity.
Clarke G; Davison I; MacMillan SJ; Wright DM
Prog Clin Biol Res; 1990; 328():351-4. PubMed ID: 2154792
[No Abstract] [Full Text] [Related]
10. The effect of mu and kappa opioid receptor agonists on cAMP level in hippocampus of kainic acid-treated rats.
Dziedzicka-Wasylewska M; Przewłocki R
Pol J Pharmacol; 1995; 47(2):121-6. PubMed ID: 8688884
[TBL] [Abstract][Full Text] [Related]
11. Influence of a mu- and kappa-opioid agonist on isoflurane minimal anesthetic concentration in chickens.
Concannon KT; Dodam JR; Hellyer PW
Am J Vet Res; 1995 Jun; 56(6):806-11. PubMed ID: 7653892
[TBL] [Abstract][Full Text] [Related]
12. Mu antagonist properties of kappa agonists in a model of rat urinary bladder motility in vivo.
Sheldon RJ; Nunan L; Porreca F
J Pharmacol Exp Ther; 1987 Oct; 243(1):234-40. PubMed ID: 2822899
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
Mitrovic I; Napier TC
J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
[TBL] [Abstract][Full Text] [Related]
14. [Synthesis and analgesic activity of 3,4-dichloro-N-methyl-N-[trans-2-(1-delta 3-pyrrolinyl)-cyclohexyl]-benzenacetamide hydrochloride].
Ma SC; Lu SN; Li KZ; Wang CQ
Yao Xue Xue Bao; 1986 Nov; 21(11):861-3. PubMed ID: 3035865
[No Abstract] [Full Text] [Related]
15. Peptide opioid antagonist separates peripheral and central opioid antitransit effects.
Shook JE; Pelton JT; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1987 Nov; 243(2):492-500. PubMed ID: 2824748
[TBL] [Abstract][Full Text] [Related]
16. Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective mu and kappa agonists.
Millan MJ; Morris BJ; Herz A
J Pharmacol Exp Ther; 1988 Nov; 247(2):721-8. PubMed ID: 2846827
[TBL] [Abstract][Full Text] [Related]
17. Respiratory effects of receptor-selective opioids in rhesus monkeys.
France CP; Woods JH
Prog Clin Biol Res; 1990; 328():295-8. PubMed ID: 2154784
[No Abstract] [Full Text] [Related]
18. Identification of a novel class of highly potent sigma ligands related to the kappa-selective agonist U50,488.
Radesca LA; deCosta BR; Bowen WD; DiPaolo LJ; Rice KC
NIDA Res Monogr; 1990; 105():518-9. PubMed ID: 1652089
[No Abstract] [Full Text] [Related]
19. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level.
Alcaraz C; Vargas ML; Fuente T; Milanés MV
J Pharmacol Exp Ther; 1993 Sep; 266(3):1602-6. PubMed ID: 8396640
[TBL] [Abstract][Full Text] [Related]
20. [Central depressor effect of U50488H: a highly selective kappa opioid agonist].
Feng Y; Han JS
Sheng Li Xue Bao; 1987 Jun; 39(3):305-9. PubMed ID: 2823391
[No Abstract] [Full Text] [Related]
[Next] [New Search]